Trial Outcomes & Findings for Non-invasive Brain Stimulation in Adults Who Stutter (NCT NCT03437512)
NCT ID: NCT03437512
Last Updated: 2021-04-29
Results Overview
Investigators will use the fMRI images taken from before and after tDCS to determine if the treatment intervention contributed to any changes within brain regions associated with speech production. This will be measured by Blood-Oxygen-Level-Dependent (BOLD) signal change (arbitrary units). Images from scans are preprocessed. Changes in BOLD signal are modeled for contrasts within a group for \[post-pre\] and \[follow up-pre\] (e.g., active group reading condition post visit MINUS active group reading pre visit). Results are reported for reading condition.
TERMINATED
NA
29 participants
Baseline, 1 week (post), 4 weeks (follow up)
2021-04-29
Participant Flow
Participants were required to meet a certain stuttering severity status. Four participants who were enrolled did not meet the pre-assignment criteria and were thus not assigned to an arm.
Participant milestones
| Measure |
Active tDCS and Fluency Training
Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days).
Anodal tDCS: 20 minutes of 2mA anodal stimulation.
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
|
Sham tDCS and Fluency Training
Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days).
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
Sham tDCS: For sham stimulation, current is ramped up and back down over 30 seconds.
|
|---|---|---|
|
Randomized
STARTED
|
12
|
13
|
|
Randomized
COMPLETED
|
12
|
11
|
|
Randomized
NOT COMPLETED
|
0
|
2
|
|
Received First tDCS Session
STARTED
|
12
|
11
|
|
Received First tDCS Session
COMPLETED
|
12
|
11
|
|
Received First tDCS Session
NOT COMPLETED
|
0
|
0
|
|
Received Final tDCS Session
STARTED
|
12
|
11
|
|
Received Final tDCS Session
COMPLETED
|
12
|
11
|
|
Received Final tDCS Session
NOT COMPLETED
|
0
|
0
|
|
Completed Study Follow up
STARTED
|
12
|
11
|
|
Completed Study Follow up
COMPLETED
|
10
|
10
|
|
Completed Study Follow up
NOT COMPLETED
|
2
|
1
|
Reasons for withdrawal
| Measure |
Active tDCS and Fluency Training
Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days).
Anodal tDCS: 20 minutes of 2mA anodal stimulation.
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
|
Sham tDCS and Fluency Training
Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days).
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
Sham tDCS: For sham stimulation, current is ramped up and back down over 30 seconds.
|
|---|---|---|
|
Randomized
Withdrawal by Subject
|
0
|
2
|
|
Completed Study Follow up
Could not complete study due to COVID-19 research pause
|
2
|
1
|
Baseline Characteristics
Non-invasive Brain Stimulation in Adults Who Stutter
Baseline characteristics by cohort
| Measure |
Active tDCS and Fluency Training
n=12 Participants
Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days).
Anodal tDCS: 20 minutes of 2mA anodal stimulation.
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
|
Sham tDCS and Fluency Training
n=11 Participants
Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days).
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
Sham tDCS: For sham stimulation, current is ramped up and back down over 30 seconds.
|
Total
n=23 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
7 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
27.43 years
STANDARD_DEVIATION 8.14 • n=5 Participants
|
23.31 years
STANDARD_DEVIATION 2.87 • n=7 Participants
|
25.46 years
STANDARD_DEVIATION 6.54 • n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
11 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
22 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Stuttering Severity
|
5.66 percent
STANDARD_DEVIATION 3.23 • n=5 Participants
|
9.72 percent
STANDARD_DEVIATION 8.88 • n=7 Participants
|
7.69 percent
STANDARD_DEVIATION 6.06 • n=5 Participants
|
|
Overall Assessment of Speaker's Experience of Stuttering
|
2.48 score on a scale
STANDARD_DEVIATION 0.58 • n=5 Participants
|
2.67 score on a scale
STANDARD_DEVIATION 0.68 • n=7 Participants
|
2.57 score on a scale
STANDARD_DEVIATION 0.64 • n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline, 1 week (post), 4 weeks (follow up)Population: One subject assigned to the sham condition did not want to participate in the MRI but participated in every other aspect of the study. Additionally, 2 subjects assigned to active and 1 assigned to sham did not complete follow up MRI due to pandemic research pause. The MRI data from one subject in the active arm was corrupted and therefore not analyzable and was excluded from MRI results. Therefore \[post-pre\] includes 11 active and 10 sham, whereas \[follow up-pre\] includes 9 active and 9 sham.
Investigators will use the fMRI images taken from before and after tDCS to determine if the treatment intervention contributed to any changes within brain regions associated with speech production. This will be measured by Blood-Oxygen-Level-Dependent (BOLD) signal change (arbitrary units). Images from scans are preprocessed. Changes in BOLD signal are modeled for contrasts within a group for \[post-pre\] and \[follow up-pre\] (e.g., active group reading condition post visit MINUS active group reading pre visit). Results are reported for reading condition.
Outcome measures
| Measure |
Active tDCS and Fluency Training
n=11 Participants
Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days).
Anodal tDCS: 20 minutes of 2mA anodal stimulation.
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
|
Sham tDCS and Fluency Training
n=10 Participants
Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days).
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
Sham tDCS: For sham stimulation, current is ramped up and back down over 30 seconds.
|
|---|---|---|
|
Changes in Brain Activation as Assessed by fMRI Images
left supplementary motor area (SMA) (post-pre)
|
1.39 Percent signal change
Standard Deviation 0.45
|
0.81 Percent signal change
Standard Deviation 0.47
|
|
Changes in Brain Activation as Assessed by fMRI Images
left SMA (fol-pre)
|
1.03 Percent signal change
Standard Deviation 0.49
|
0.9 Percent signal change
Standard Deviation 0.54
|
|
Changes in Brain Activation as Assessed by fMRI Images
right SMA (post-pre)
|
-0.45 Percent signal change
Standard Deviation 0.48
|
0.49 Percent signal change
Standard Deviation 0.52
|
|
Changes in Brain Activation as Assessed by fMRI Images
right SMA (fol-pre)
|
0.86 Percent signal change
Standard Deviation 0.54
|
0.09 Percent signal change
Standard Deviation 0.35
|
|
Changes in Brain Activation as Assessed by fMRI Images
left superior temporal gyrus (STG) (post-pre)
|
1.43 Percent signal change
Standard Deviation 0.74
|
0.79 Percent signal change
Standard Deviation 0.75
|
|
Changes in Brain Activation as Assessed by fMRI Images
left STG (fol-pre)
|
0.09 Percent signal change
Standard Deviation 0.53
|
0.57 Percent signal change
Standard Deviation 0.85
|
|
Changes in Brain Activation as Assessed by fMRI Images
right STG (post-pre)
|
-0.63 Percent signal change
Standard Deviation 0.97
|
1.56 Percent signal change
Standard Deviation 1.39
|
|
Changes in Brain Activation as Assessed by fMRI Images
right STG (fol-pre)
|
0.3 Percent signal change
Standard Deviation 1.07
|
0.83 Percent signal change
Standard Deviation 1.17
|
|
Changes in Brain Activation as Assessed by fMRI Images
left putamen (post-pre)
|
1.37 Percent signal change
Standard Deviation 0.66
|
-0.31 Percent signal change
Standard Deviation 0.58
|
|
Changes in Brain Activation as Assessed by fMRI Images
left putamen (fol-pre)
|
2.42 Percent signal change
Standard Deviation 0.71
|
-0.22 Percent signal change
Standard Deviation 0.59
|
|
Changes in Brain Activation as Assessed by fMRI Images
right putamen (post-pre)
|
-1.01 Percent signal change
Standard Deviation 0.65
|
-0.74 Percent signal change
Standard Deviation 0.67
|
|
Changes in Brain Activation as Assessed by fMRI Images
right putamen (fol-pre)
|
0.89 Percent signal change
Standard Deviation 0.69
|
0.06 Percent signal change
Standard Deviation 0.86
|
|
Changes in Brain Activation as Assessed by fMRI Images
left inferior frontal gyrus (IFG) (post-pre)
|
1.6 Percent signal change
Standard Deviation 0.94
|
-0.33 Percent signal change
Standard Deviation 0.97
|
|
Changes in Brain Activation as Assessed by fMRI Images
left IFG (fol-pre)
|
0.23 Percent signal change
Standard Deviation 0.96
|
0.14 Percent signal change
Standard Deviation 0.74
|
|
Changes in Brain Activation as Assessed by fMRI Images
right IFG (post-pre)
|
-0.48 Percent signal change
Standard Deviation 0.80
|
0.11 Percent signal change
Standard Deviation 0.65
|
|
Changes in Brain Activation as Assessed by fMRI Images
right IFG (fol-pre)
|
-0.2 Percent signal change
Standard Deviation 0.80
|
-0.2 Percent signal change
Standard Deviation 0.80
|
|
Changes in Brain Activation as Assessed by fMRI Images
left premotor cortex (PMC) (post-pre)
|
1.33 Percent signal change
Standard Deviation 0.91
|
-0.15 Percent signal change
Standard Deviation 1.67
|
|
Changes in Brain Activation as Assessed by fMRI Images
left PMC (fol-pre)
|
0.68 Percent signal change
Standard Deviation 0.96
|
0.62 Percent signal change
Standard Deviation 1.11
|
|
Changes in Brain Activation as Assessed by fMRI Images
right PMC (post-pre)
|
0.31 Percent signal change
Standard Deviation 0.72
|
1.2 Percent signal change
Standard Deviation 0.93
|
|
Changes in Brain Activation as Assessed by fMRI Images
right PMC (fol-pre)
|
1.32 Percent signal change
Standard Deviation 1.01
|
1.01 Percent signal change
Standard Deviation 1.17
|
PRIMARY outcome
Timeframe: Baseline, 1 week (post), 4 weeks (follow up)Investigators will calculate the percentage of stuttered syllables (out of total syllables) in a speech sample. Decreased stuttered syllables represents better outcomes (greater reduction in stuttering).
Outcome measures
| Measure |
Active tDCS and Fluency Training
n=12 Participants
Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days).
Anodal tDCS: 20 minutes of 2mA anodal stimulation.
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
|
Sham tDCS and Fluency Training
n=11 Participants
Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days).
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
Sham tDCS: For sham stimulation, current is ramped up and back down over 30 seconds.
|
|---|---|---|
|
Change in Percentage of Stuttered Syllables Produced During Speech Sample
% Change post
|
-1.82 percent change in stuttered syllables
Standard Deviation 2.22
|
1.06 percent change in stuttered syllables
Standard Deviation 2.02
|
|
Change in Percentage of Stuttered Syllables Produced During Speech Sample
% Change follow up
|
-1.03 percent change in stuttered syllables
Standard Deviation 4.17
|
3.46 percent change in stuttered syllables
Standard Deviation 5.47
|
SECONDARY outcome
Timeframe: Baseline, 1 week (post), 4 weeks (follow up)The OASES is a standardized assessment of the functional impact of stuttering on a person's life. There are 4 sub-tests: general information about speech, your reactions to stuttering, communication in daily situations, quality of life. Each one has a score from 1 to 5 with regard to impact (1 least, 5 most negative impact). These are combined to give a total impact score between 1 and 5, with 5 representing the highest negative impact on person's life. The change on the total impact score will be used. Changes are shown in the table below by comparison between the measurements at the three points in time.
Outcome measures
| Measure |
Active tDCS and Fluency Training
n=12 Participants
Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days).
Anodal tDCS: 20 minutes of 2mA anodal stimulation.
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
|
Sham tDCS and Fluency Training
n=11 Participants
Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days).
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
Sham tDCS: For sham stimulation, current is ramped up and back down over 30 seconds.
|
|---|---|---|
|
Changes From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)
Pre
|
2.48 score on a scale
Standard Deviation .61
|
2.67 score on a scale
Standard Deviation .75
|
|
Changes From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)
Post
|
2.34 score on a scale
Standard Deviation .55
|
2.56 score on a scale
Standard Deviation .78
|
|
Changes From Baseline on the Overall Assessment of Speakers Experience of Stuttering (OASES)
Follow up
|
2.35 score on a scale
Standard Deviation .57
|
2.59 score on a scale
Standard Deviation .88
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, 1 week, 4 weeksInvestigators will compare performance accuracy on a computerized rhythm judgement task from before and after tDCS to assess effects of tDCS. Improved accuracy reflects better performance.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, 1 week, 4 weeksInvestigators will compare performance on computerized tapping tasks from before and after tDCS to assess effects of tDCS.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, 1 week, 4 weeksInvestigators will compare participant scores on a self-rated measure of speech fluency (1 = NO STUTTERING; 9 = EXTREMELY SEVERE STUTTERING) from before and after tDCS to assess effects of tDCS. Lower scores indicate improvement.
Outcome measures
Outcome data not reported
Adverse Events
Active tDCS and Fluency Training
Sham tDCS and Fluency Training
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Active tDCS and Fluency Training
n=12 participants at risk
Participants will receive anodal tDCS at 2milliampere (mA) intensity for 20 minutes during speech fluency training (5 consecutive days).
Anodal tDCS: 20 minutes of 2mA anodal stimulation.
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
|
Sham tDCS and Fluency Training
n=11 participants at risk
Participants will receive sham tDCS. Sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes of speech fluency training (5 consecutive days).
Fluency training: Speaking along with a metronome and/or speaking along with another person (choral speech) for 20 minutes
Sham tDCS: For sham stimulation, current is ramped up and back down over 30 seconds.
|
|---|---|---|
|
General disorders
Headache
|
33.3%
4/12 • 6 weeks
|
18.2%
2/11 • 6 weeks
|
|
Musculoskeletal and connective tissue disorders
Neck pain
|
8.3%
1/12 • 6 weeks
|
27.3%
3/11 • 6 weeks
|
|
Skin and subcutaneous tissue disorders
Scalp pain
|
66.7%
8/12 • 6 weeks
|
72.7%
8/11 • 6 weeks
|
|
Skin and subcutaneous tissue disorders
Tingling
|
100.0%
12/12 • 6 weeks
|
90.9%
10/11 • 6 weeks
|
|
Skin and subcutaneous tissue disorders
Warm sensation
|
83.3%
10/12 • 6 weeks
|
72.7%
8/11 • 6 weeks
|
|
General disorders
Sleepiness
|
75.0%
9/12 • 6 weeks
|
72.7%
8/11 • 6 weeks
|
|
General disorders
Trouble concentrating
|
41.7%
5/12 • 6 weeks
|
45.5%
5/11 • 6 weeks
|
|
General disorders
Acute mood change
|
8.3%
1/12 • 6 weeks
|
18.2%
2/11 • 6 weeks
|
|
General disorders
Fatigue
|
50.0%
6/12 • 6 weeks
|
36.4%
4/11 • 6 weeks
|
|
General disorders
Nervousness
|
8.3%
1/12 • 6 weeks
|
36.4%
4/11 • 6 weeks
|
|
General disorders
Changes in visual sensations
|
0.00%
0/12 • 6 weeks
|
27.3%
3/11 • 6 weeks
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place